Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.

MLA

Akiyama, Junichi, et al. “Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.” Digestion, vol. 101, no. 2, Feb. 2020, pp. 174–83. EBSCOhost, https://doi.org/10.1159/000497775.

APA

Akiyama, J., Hosaka, H., Kuribayashi, S., Moriyasu, S., Hisada, Y., Okubo, H., Watanabe, K., Imbe, K., Nagata, N., Kojima, Y., Yokoi, C., Uemura, N., Shimoyama, Y., Kawamura, O., Yamada, M., & Kusano, M. (2020). Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux. Digestion, 101(2), 174–183. https://doi.org/10.1159/000497775

Chicago

Akiyama, Junichi, Hiroko Hosaka, Shiko Kuribayashi, Shiori Moriyasu, Yuya Hisada, Hidetaka Okubo, Kazuhiro Watanabe, et al. 2020. “Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.” Digestion 101 (2): 174–83. doi:10.1159/000497775.